List of SBIR/STTR awards granted to Angion Biomedica Corp.

where

SBIR/STTR Award Recipient

Angion Biomedica Corp.

Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ Angion Biomedica Corp. SBIR Phase I Award, April 2019	A SBIR Phase I contract was awarded to Angion Biomedica Corp. in April, 2019 for $220,731.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Angion Biomedica Corp.		National Institutes of Health	SBIR	1R43DK121642-01	Phase I	220,731	April 1, 2019	sbir.gov/node/1680139
‌ Angion Biomedica Corp. SBIR Phase I Award, September 2017	A SBIR Phase I contract was awarded to Angion Biomedica Corp. in September, 2017 for $222,670.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43DK116404-01	Phase I	222,670	September 15, 2017	sbir.gov/node/1326363
‌ Angion Biomedica Corp. SBIR Phase I Award, September 2017	A SBIR Phase I contract was awarded to Angion Biomedica Corp. in September, 2017 for $219,546.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43DK116452-01	Phase I	219,546	September 15, 2017	sbir.gov/node/1326333
‌ Angion Biomedica Corp. SBIR Phase II Award, April 2016	A SBIR Phase II contract was awarded to Angion Biomedica Corp. in April, 2016 for $1,320,083.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44DK095625-02A1	Phase II	1,320,083	April 1, 2016	sbir.gov/node/1165251
‌ Angion Biomedica Corp. SBIR Phase I Award, January 2014	A SBIR Phase I contract was awarded to Angion Biomedica Corp. in January, 2014 for $149,761.0 USD from the National Science Foundation.	Angion Biomedica Corp.	National Science Foundation		SBIR	1345892	Phase I	149,761	January 1, 2014	sbir.gov/node/704321
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $299,948.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43AI110004-01	Phase I	299,948		sbir.gov/node/705147
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $295,467.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43HL088800-01A2	Phase I	295,467		sbir.gov/content/novel-small-molecule-adjuvants-drug-eluting-stents-0
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $190,321.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43DK064455-01	Phase I	190,321		sbir.gov/content/hepatocyte-growth-factor-mimetic-liver-fibrosis-0
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,664,290.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44DK066654-05	Phase II	1,664,290		sbir.gov/content/pilot-clinical-study-renal-transplantation-0
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $197,752.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43HL074537-01	Phase I	197,752		sbir.gov/content/protection-atherosclerosis-c-met-agonist-0
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $229,277.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43NS062625-01	Phase I	229,277		sbir.gov/content/parp-1-inhibitors-therapy-treatment-stroke-0
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $200,594.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43CA130506-01A1	Phase I	200,594		sbir.gov/content/anti-angiogenic-and-tumorcidal-drugs-against-lung-carcinoma-0
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $900,132.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44AA016457-02	Phase II	900,132		sbir.gov/node/1070239
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,335,726.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44DK078455-02	Phase II	1,335,726		sbir.gov/content/unique-clinical-study-dgf-using-paired-kidneys
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $224,347.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43AA023432-01	Phase I	224,347		sbir.gov/node/704991
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $234,658.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43HL091688-01	Phase I	234,658		sbir.gov/content/therapeutic-potential-small-molecule-compound-emphysema-0
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $942,288.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44NS053152-02	Phase II	942,288		sbir.gov/content/novel-small-molecule-therapeutic-spinal-cord-injury-2
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44HL062048-02A1	Phase I	0		sbir.gov/content/sfhgf-gene-transfer-peripheral-ischemia-0
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $290,570.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43DK078455-01A2	Phase I	290,570		sbir.gov/content/phase-i-study-bb3-dialysis-patients-0
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $183,826.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43CA128164-01	Phase I	183,826		sbir.gov/content/novel-c-met-and-tie-2-antagonists-against-human-glioma-0
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,827,834.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44DK062592-02	Phase II	2,827,834		sbir.gov/content/renal-injury-prevention-sfhgf-small-molecules-2
‌ Angion Biomedica Corp. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $327,272.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	1R43AA018895-01	Phase I	327,272		sbir.gov/content/novel-therapeutic-alcoholic-liver-disease-0
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,914,840.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44HL091699-02A2	Phase II	2,914,840		sbir.gov/node/1707
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,087,768.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44AA020163-02	Phase II	2,087,768		sbir.gov/node/388917
‌ Angion Biomedica Corp. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,979,147.0 USD from the U.S. Department of Health & Human Services.	Angion Biomedica Corp.			SBIR	2R44AA015223-04	Phase II	2,979,147		sbir.gov/content/safety-and-pk-study-hepatic-impairment-patients-0

Results per page:

76 results

0 selected

76 results

0 selected